Paired Comparison of Routine Molecular Screening of Patient Samples with Advanced Non-Small Cell Lung Cancer in Circulating Cell-Free DNA Using Three Targeted Assays.
David BarthelemyGaelle LescuyerFlorence GeiguerEmmanuel GrolleauArnaud GauthierJulie BalandierMargaux RaffinClaire BardelBruno BouyssounouseClaire Rodriguez-LafrasseSébastien CouraudAnne-Sophie WoznyLéa PayenPublished in: Cancers (2023)
The Plasma-SeqSensei™ SOLID CANCER IVD kit resulted in de novo detection of targetable oncogenic drivers and resistance alterations, with a high sensitivity and accuracy for low and high cfDNA inputs. Thus, this assay is a sensitive, robust, and accurate test.
Keyphrases
- advanced non small cell lung cancer
- epidermal growth factor receptor
- high throughput
- papillary thyroid
- case report
- squamous cell
- clinical practice
- high resolution
- cancer therapy
- loop mediated isothermal amplification
- transcription factor
- real time pcr
- label free
- tyrosine kinase
- single molecule
- squamous cell carcinoma
- young adults
- sensitive detection